European Archives - Page 1071 of 1281 - European Medical Journal

Acute Intermittent Porphyria in Elderly Patients Undergoing Chronic Haemodialysis: Resolution of Tetraplegia with Systemic Haemin and Rehabilitation

Porphyrias are inherited defects in the biosynthesis of haem.

New Therapies Targeting Cystogenesis in Autosomal Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease and results from mutations in the polycystin 1 gene (PKD1) or…

Comparison of Fluid Status in a Prevalent Haemodialysis and Peritoneal Dialysis Cohort: A Retrospective Analysis

Euvolaemia is a major issue in chronic kidney disease, as volume overload (VO) is related to cardiac dysfunction, inflammation, and mortality.

Malnutrition in Chronic Haemodialysis Patients: Effects of Intradialytic Parenteral Nutritional Therapy on Serum Albumin and Total Protein, BMI, and Phase Angle in Selected Patients

Malnutrition is a common problem that is associated with unfavourable clinical progression, more frequent hospitalisation, and increased mortality in…

Kidney Volume Evaluation in Autosomal Dominant Polycystic Kidney Disease Patients’ Renal Outcomes

Autosomal dominant polycystic kidney disease patients show end-stage renal disease progression, which requires suitable biomarkers to identify.

Neopterin, MCP-1, and MCSF as New Markers of Tubular Damage in Children with Chronic Kidney Disease on Conservative Treatment

Chronic kidney disease is characterised by enhanced migration of immunocompetent cells to the sites of inflammation, renal fibrosis, and irreversible…

Basal Forebrain Atrophy and Elevated Plasmatic Homocysteine Levels in Dementia Patients

Ondrej Lerch, MD from Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic discusses a study…

EuroPCR 2017 – Opening Ceremony

Our full congress review of EuroPCR 2017 is out now in our Interventional Cardiology 5.1 eJournal, and here we give you a look into the opening ceremony…

EMJ

ASSIST-FL – Primary Outcome: Interview with Prof. Jurczak

In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded…

RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

Tel-Aviv, Israel / Raleigh, NC, USA, 12 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…